New healthtech products are great. But building on consumers’ needs and payer priorities will vastly increase the value created.

With stagnant revenue and increasing carrier demands, PCP practices need to reduce the number of payer contracts and reduce overhead.

If vaccinations become a personal choice, then the costs associated with that choice should be transparent and apportioned appropriately.